Health Care & Life Sciences » Biotechnology | BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
14,467.20
14,077.10
22,750.10
26,251.00
27,443.80
32,961.40
SG&A Expense
6,458.50
6,830.60
7,373.80
7,533.00
9,700.60
9,487.80
EBIT
7,944.50
6,999.40
14,443.30
17,026.40
17,678.20
23,398.70
Non Operating Income/Expense
-
1.20
14.70
52.80
51.10
104
Pretax Income
7,970.70
7,032.70
14,551.00
17,375.00
18,365.80
24,797.30
Income Tax
2,684.80
2,386.70
4,933.30
6,002.80
7,037.50
4,744
Consolidated Net Income
5,285.80
4,646.00
9,617.60
11,372.20
11,328.30
20,053.30
Net Income
5,285.80
4,646.00
9,617.60
11,372.20
11,328.30
20,053.30
Net Income After Extraordinaries
5,285.80
4,646.00
9,617.60
11,372.20
11,328.30
20,053.30
Net Income Available to Common
5,285.80
4,646.00
9,617.60
11,372.20
11,328.30
20,053.30
EPS (Basic)
0.76
0.66
1.32
1.56
1.55
2.73
Basic Shares Outstanding
6,345.60
6,477.50
6,827.40
7,061.40
7,170.70
7,242.20
EPS (Diluted)
0.76
0.66
1.32
1.56
1.55
2.73
Diluted Shares Outstanding
6,922.30
7,079.60
7,273.00
7,283.30
7,321.80
7,333.40
EBITDA
8,008.80
7,246.50
15,376.30
18,718.00
17,743.20
23,473.70
Non-Operating Interest Income
26.20
32.20
92.90
295.80
636.60
1,294.70

About BioSpecifics Technologies

View Profile
Address
35 Wilbur Street
Lynbrook New York 11563
United States
Employees -
Website http://www.biospecifics.com
Updated 07/08/2019
BioSpecifics Technologies Corp. engages in the development of an injectable collagenase for multiple indications. Its products include XIAFLEX, which is a treatment used for Dupuytren's contracture. The company was founded in 1990 and is headquartered in Lynbrook, NY.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.